KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Inventory (2016 - 2026)

CareDx's Inventory history spans 14 years, with the latest figure at $26.4 million for Q1 2026.

  • On a quarterly basis, Inventory rose 15.16% to $26.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $26.4 million, a 15.16% increase, with the full-year FY2025 number at $26.7 million, up 36.93% from a year prior.
  • Inventory hit $26.4 million in Q1 2026 for CareDx, down from $26.7 million in the prior quarter.
  • Over the last five years, Inventory for CDNA hit a ceiling of $28.3 million in Q3 2025 and a floor of $18.0 million in Q3 2023.
  • Historically, Inventory has averaged $21.1 million across 5 years, with a median of $19.3 million in 2024.
  • Biggest five-year swings in Inventory: fell 3.8% in 2022 and later soared 47.06% in 2025.
  • Tracing CDNA's Inventory over 5 years: stood at $19.2 million in 2022, then rose by 1.24% to $19.5 million in 2023, then grew by 0.16% to $19.5 million in 2024, then skyrocketed by 36.93% to $26.7 million in 2025, then decreased by 1.13% to $26.4 million in 2026.
  • Business Quant data shows Inventory for CDNA at $26.4 million in Q1 2026, $26.7 million in Q4 2025, and $28.3 million in Q3 2025.